Helix BioPharma Corp. (HBP.TO) TSX

2.15

+0(+0.00%)

Updated at January 14 09:30AM

Currency In CAD

Valuation

Market Cap59.64M
Enterprise Value59.91M
P/E Ratio-33.45
PEG Ratio-1.23
Price/Sales Ratio0
Price/Book Ratio10.15
Enterprise/Revenue0
Enterprise/EBITDA-35.48

Fiscal Year

Fiscal YearJuly 31, 2025
Most Recent QuarterOctober 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.26
Return On Equity-0.65

Income Statement

Revenue0
Revenue/Share0
Gross Profit-10,000
EBITDA-5.21M
Net Income-5.21M
Diluted EPS-0.09

Balance Sheet

Total Cash498,000
Total Cash/Share0.01
Total Debt352,000
Total Debt/Equity0.02
Current Ratio0.23
Book Value Per Share0.21

Price History

52-Week Change138.89
52-Week High5.4
52-Week Low0.65
Moving Average 50 Days2.26
Moving Average 200 Days1.54

Statistics

Average Volume2,688
Shares Outstanding76.38M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateAugust 16, 2024